International consortium launched to develop new treatments for childhood brain tumours
Launched this month, The Children’s Brain Tumour Drug Delivery Consortium is an international collaboration that aims to explore novel drug delivery systems that can physically bypass the blood brain barrier. Led by Professor David Walker at The University of Nottingham, UK, the initiative has received two years' funding from the charity Children with Cancer UK, and among the consortium’s activities are to organise and host discussions of an international, multi-disciplinary network of clinicians and researchers. (IBTA Newsletter March 2017)
The first NHS proton beam machine has arrived at Manchester’s Christie Hospital
This machine will enable cancer patients to receive high energy proton beam therapy (PBT) on the NHS for the first time.
Manchester’s Christie hospital will be the first NHS unit to provide the treatment, meaning patients needing PBT will no longer have to go abroad.
The new unit is due to open in August 2018.
Proton beam therapy is useful for treating types of cancer in critical areas – when it is important to reduce damage to surrounding tissue as much as possible.
For example, it is used most often to treat brain tumours in young children whose brains are still developing.
Doctorate research into how children with brain tumours are supported at school is going well. Vicky has successfully completed year 1 of a Doctorate in Education and is currently preparing for year 2. We are excited about this much needed area of research as it is directly informing practice within schools.
Levi’s Star aims to disseminate findings across the UK and internationally, as we recognise the importance of the quality of survivorship for children and young people who have survived brain tumours.
Please call us if you would like further details.